FDA Holds Off Approval of New Merck Drug
As expected, the FDA is holding off on Merck’s new COX-2, Arcoxia. I’ve been bombarded with ads saying it’s “coming soon”. I guess not.
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.